Epidemiological, clinical, pathological and genetic characteristics of epidermolysis bullosa in New Zealand-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Epidemiological, clinical, pathological and genetic characteristics of epidermolysis bullosa in New Zealand

Published:2021-12-14 Issue: Volume: Page:
ISSN:0004-8380
Container-title:Australasian Journal of Dermatology
language:en
Short-container-title:Australas J Dermatol

Author:

Gear Russell¹^ORCID,Poke Gemma¹,Neas Katherine¹,Finnigan Jacqui²,Cassidy Sharon²³,Forsyth Deanna²,Blishen Mo²,Purvis Diana⁴

Affiliation:

1. Genetics Health Service NZ Central Hub Wellington Hospital Capital and Coast District Health Board Wellington New Zealand

2. Dystrophic Epidermolysis Bullosa Research Association of New Zealand Wellington New Zealand

3. Child Health Service Canterbury District Health Board Christchurch New Zealand

4. Dermatology Department Starship Hospital Auckland District Health Board Auckland New Zealand

Funder

Debra International

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajd.13762

Reference18 articles.

1. Inherited epidermolysis bullosa: Updated recommendations on diagnosis and classification

2. Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility

3. Clinical practice guidelines for laboratory diagnosis of epidermolysis bullosa

4. Studies on the Pathogenesis of Epidermolysis Bullosa**From the Section of Dermatology, Department of Medicine, University of Chicago, Chicago 37, Illinois.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epidemiological Characteristics of Inherited Epidermolysis Bullosa in an Eastern European Population;Journal of Clinical Medicine;2024-06-26

2. Gene-edited cells: novel allogeneic gene/cell therapy for epidermolysis bullosa;Journal of Applied Genetics;2024-03-09

3. Stop codon readthrough as a treatment option for epidermolysis bullosa—Where we are and where we are going;Experimental Dermatology;2024-03

4. Highly efficient CRISPR/Cas9‐mediated exon skipping for recessive dystrophic epidermolysis bullosa;Bioengineering & Translational Medicine;2024-01-17

5. French data on the epidemiology and expert healthcare network for epidermolysis bullosa;Journal of the European Academy of Dermatology and Venereology;2023-01-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3